The shortness of breath started on a walk that had never winded me before. It was easy to chalk up to being 'out of shape' — and that assumption delayed the right conversation with a doctor by over a year. If breathing feels harder than it used to and nothing obvious explains it, hormones deserve a place in that conversation.
Learn more about Rose →Estrogen has a bronchodilatory effect — it helps keep airways open and reduces airway inflammation. When estrogen drops, this protective effect diminishes, and studies show that women who were never asthmatic before can develop asthma for the first time during perimenopause or after menopause. Research from the European Respiratory Journal found postmenopausal women had significantly higher rates of asthma onset compared to premenopausal women of similar age, independent of smoking history.
Women who already have asthma frequently report that their symptoms worsen noticeably during perimenopause, with more frequent flares and a reduced response to the same medications that previously worked well. Fluctuating progesterone and estrogen levels affect airway hyperresponsiveness — the tendency of airways to tighten in response to triggers. Tracking symptom changes alongside menstrual cycle or hormone status can help a doctor distinguish true asthma progression from hormone-driven variability.
Before menopause, women are significantly less likely than men to develop obstructive sleep apnea — after menopause, that gap closes considerably, with risk increasing two- to threefold. Progesterone, which acts as a respiratory stimulant and helps maintain upper airway muscle tone during sleep, declines sharply in the menopause transition. Because sleep apnea in women often presents with insomnia, fatigue, and mood changes rather than loud snoring, it is routinely missed or misattributed to menopause itself.
Estrogen and progesterone both play a role in maintaining skeletal muscle function, including the diaphragm and the intercostal muscles between the ribs that drive breathing. As hormone levels fall, these muscles are subject to the same loss of strength and endurance seen elsewhere in the body — a process accelerated by the drop in anabolic hormonal signalling. Women may notice they feel breathless more quickly during exercise or that deep breathing requires noticeably more effort than it used to.
Spirometry studies — tests that measure how much air lungs can move — show that FEV1 (the volume exhaled in one second) and FVC (total forced vital capacity) decline at a steeper rate after menopause compared to before. The Copenhagen City Heart Study and similar large cohort studies have linked earlier menopause with lower lung function in later life, suggesting cumulative estrogen exposure matters for respiratory health over time. This doesn't mean lungs are diseased, but it does mean the functional reserve available during illness or exertion shrinks.
Estrogen helps maintain the moisture and integrity of mucous membranes throughout the body — including the airways. As levels fall, the respiratory tract can become drier and more easily irritated, leading to a persistent dry cough, increased sensitivity to cold air or smoke, and a sensation of tightness that isn't classic asthma but is genuinely uncomfortable. This is the respiratory equivalent of vaginal dryness and responds to some of the same underlying hormonal drivers.
During a hot flash, the cardiovascular and autonomic nervous systems fire simultaneously — heart rate rises, blood vessels dilate, and many women experience a sudden sensation of breathlessness or an inability to catch their breath alongside the heat surge. This isn't a lung problem; it's the body's thermoregulatory response creating a temporary mismatch between breathing demand and supply. For women with underlying respiratory sensitivity, however, this repeated physiological stress can compound airway reactivity over time.
Estrogen has well-documented anti-inflammatory effects, partly by modulating mast cells and eosinophils — the immune cells most involved in allergic airway inflammation. When estrogen declines, this modulation is reduced, making airways more reactive to allergens, pollutants, and respiratory infections. Women in perimenopause and beyond may find that seasonal allergies they managed easily before now tip into bronchospasm, or that respiratory illnesses take longer to recover from than they did in their thirties.
Several observational studies suggest that menopausal hormone therapy (MHT) is associated with reduced risk of asthma onset and slower decline in lung function, consistent with estrogen's known airway-protective effects. However, some studies — including findings from the Women's Health Initiative — found that combined estrogen-progestogen therapy was associated with slightly increased asthma risk in certain subgroups, which may relate to the specific type of progestogen used. Anyone with respiratory concerns alongside menopause symptoms has good reason to raise this with their prescribing doctor, as the type and route of hormones may matter.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.